IVI RMA Global and Lavima Fertility join forces in research in fertility treatments
VALENCIA, Spain and BRUSSELS, July 03, 2024 (GLOBE NEWSWIRE) -- Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconveniences that the process of ovarian stimulation can generate are a current barrier for some women and couples who are considering starting a reproductive treatment. In fact, 1 out of every 5 couples do not start the search for a second child for this reason.
Ovarian stimulation is the initial part of assisted reproduction treatments, and it is the phase of infertility treatments in which the least relevant advances have been achieved to date. It is one of the main psychological barriers for women when deciding to begin this path towards motherhood. Many of them are concerned about how this process may affect them physically and emotionally.
With the aim of making progress in this field, IVI RMA GLOBAL has signed an exclusive agreement with Lavima Fertility, Inc., a US company in the fertility sector which owns the rights to CAPA-IVM, a completely novel hormone-free fertility treatment technology. Together, IVI RMA Global and Lavima Fertility have opened a pioneering line of research aimed at eliminating ovarian stimulation in women who wish to begin assisted reproduction or egg vitrification treatment.
'We are aware that the ovarian stimulation phase can be faced with some anxiety and can be a brake on the decision to begin treatment. For this reason, at IVI and together with Lavima Fertility, we have taken the initiative and we are going to challenge science to try to optimize this very delicate part of the treatment for some patients,' explains Dr. Nuria Pellicer, gynecologist at IVI Valencia.
A clinical study has begun at the IVI Valencia headquarters under the direction of Dr. Ernesto Bosch, director of the clinic, and Dr. Nuria Pellicer, together with the scientific director of IVI RMA Global, Dr. Juan Antonio García Velasco. Lavima Fertility is supporting this clinical study by providing the CAPA-IVM and culture media supplements that allow immature oocytes to mature outside of the women’s ovaries in vitro and without the need of ovarian stimulation. This investigation will later be joined by the rest of the IVI RMA Global group's clinics.
'Our main objective is to continue benefiting women through research, and to eliminate the psychological barrier of those who decide not to start treatment, worried about the physical and emotional effect that ovarian stimulation may have on them, although the symptoms associated with this process are usually moderate and pass in a few days,' says Dr. Bosch.
In spite of being a fundamental step in the treatment of fertility, it is estimated that 20% of couples who would like to look for a second child do not do so due to their reluctance regarding the possible effects of ovarian stimulation: 'Finding formulas to improve this process from science is an exciting and hopeful project for us, in our continuous research work, and allows us to continue helping in a pioneering way and with the latest advances to women who trust us with their greatest desire,' concludes Dr. Pellicer.
'Avoiding controlled ovarian stimulation together with the trigger hormones in ART represents clearly a great scientific and clinical innovation,' says Prof. Dr. Johan Smitz from Lavima Fertility.
Immature eggs are retrieved from unstimulated small follicles. The oocyte-cumulus-complexes are then matured in a novel two-step process in vitro using several culture media supplements. This technology is called CAPA-IVM. Five randomized clinical studies have been conducted in Asia and over 850 babies have been born already using this novel hormone free fertility treatment technology, underlying the safety of CAPA-IVM.
'We are excited about the research collaboration between IVI RMA Global and Lavima Fertility in the field of hormone-free fertility treatment. IVI RMA Global is the largest IVF chain in the world and working together with IVI RMA Global clinics in this field would allow to bring CAPA-IVM to many more patients worldwide in the future,' concludes Prof. Smitz.
About IVI
IVI was founded in 1990 as the first medical institution in Spain to specialize entirely in Human Reproduction. Since then, it has helped more than 250,000 children to be born thanks to constant innovation and the development of the most innovative assisted reproduction treatments.
It is one of the European centers with the best pregnancy rates; in fact, most couples who consult IVI for infertility problems achieve their goal. In addition, it has a team of more than 2,500 professionals, including the best gynecologists in the world.
IVI is part of the IVI RMA Global group, present in 15 countries. In addition to Spain, it is present in Portugal, Italy, the Czech Republic, the Nordic countries, United Kingdom, USA, Canada, Panama, Brazil and Chile.
For more information:
Lucía Renau lucia.renau@ivirma.com
Ricardo Pedrós ricardo.pedros@ivirma.com
APPLE TREE
Anaïs Priego ap@appletree.agency
Clara Martínez cla@appletree.agency
About Lavima Fertility, Inc.
Lavima Fertility was founded in 2020 as a spin-off from the Free University of Brussels (VUB). Lavima owns the worldwide exclusive license to the CAPA-IVM technology which was originally developed at Free University of Brussels by Prof. Johan Smitz and co-workers. The CAPA-IVM technology is a novel, completely hormone free fertility treatment technology. Several thousands of patients have been treated with CAPA-IVM in Asian countries and Australia. More than 850 babies have been born after CAPA-IVM cycles. The CAPA-IVM technology is protected by granted patents in major territories. Lavima Fertility is cooperating with leading IVF clinics to evaluate the CAPA-IVM technology for various patient cohorts with the aim to further optimize the technology and complete the clinical development of the CAPA-IVM System Kit.
www.lavimafertility.com
For more information:
Andé Rosenthal andre.rosenthal@lavimafertility.com
Johan Smitz johan.smitz@lavimafertility.com

TIN LIÊN QUAN
Luxury Fertility & Surrogacy Concierge, First-of-Its-Kind.
A new paradigm in which luxury fertility is an experience. Because the world's wealthy don't have time to create their families, as they're busy creating...
Neuronetics Sponsors the 5th International Brain
Poster Session Highlights the Strong Dose-Response Relationship and the Importance of Treating Beyond 30 Treatments With NeuroStar Advanced Therapy...
Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2250a8861042&size=3[/img]
THỦ THUẬT HAY
Cách tính sim thăng quan tiến chức chuẩn nhất từ chuyên gia
Sim thăng quan tiến chức là gì? Liệu sử dụng sim thăng tiến này có thể giúp người dùng gặp nhiều thuận lợi và hanh thông trong sự nghiệp công danh hay không?
Hướng dẫn thiết lập tự động trả lời tin nhắn trên Fanpage Facebook
Nếu sở hữu một Fanpage Facebook để bán hàng online hoặc để sử dụng vào một mục đích nào đó mà bạn muốn. Khi đó nếu người người dùng hoặc khách hàng muốn bạn tư vấn, họ sẽ gửi tin nhắn cho bạn trên Fanpage.
Đăng nhập vào điện thoại Windows 10 khi quên mã PIN
Nếu vô tình bạn quên mật khẩu trên chiếc điện thoại chạy Windows 10 Mobile thì phải làm như thế nào? Khá may mắn là có 1 cách vô cùng đơn giản để...
Cách tăng trải nghiệm, sự ổn định khi chơi game trên Windows 10
Windows 10 April 2018 được bổ sung thêm tính năng giúp tập trung tối đa sức mạnh GPU (card màn hình) vào trò chơi bạn đã chỉ định trước đó. Đây chính là điểm mấu chốt giúp tăng tốc độ xử lý và trải nghiệm cho game thủ.
Cách tích hợp driver USB 3.0 vào bộ cài Windows 7 nhanh nhất
Các laptop hiện nay đều được tích hợp ít nhất một cổng USB 3.0, thậm chí là thay thế toàn bộ các cổng USB 2.0. Đa số các kỹ thuật viên hay người dùng phổ thông, khi cài windows 7 đều gặp lỗi khi cài trên các laptop cũ
ĐÁNH GIÁ NHANH
BMW X2 khác biệt cả về thiết kế và trang bị so với "đàn anh" X1
Về cơ bản BMW X2 là phiên bản thiết kế thể thao của người anh em X1. Không quá ngạc nhiên khi ngoại thất của X2 có ngôn ngữ thiết kế hiện đại hơn so với 'đàn anh' X1.
Tầm 7 triệu mua điện thoại nào cấu hình mạnh, thiết kế đẹp?
Nếu bạn đang có ý định mua một chiếc điện thoại ngoại hình bắt mắt cùng cấu hình mạnh mẽ trong tầm giá 7 triệu thì không nên bỏ qua bài viết bên ...
Đánh giá camera Zenfone 3 Max 5,5 inch: Nhiều tính năng,...
Thế giới di động - Tuy không được Asus nhấn mạnh vào camera mà nhấn mạnh vào pin, nhưng Zenfone 3 Max phiên bản 5,5 inch lại có một camera rất khá so với các sản...